Experimental Trauma Surgery, Department of Orthopedics and Trauma Surgery, University Medical Center Schleswig-Holstein, 24105 Kiel, Germany.
Functional Nanomaterials, Institute for Materials Science, Kiel University, Kaiser Str. 2, 24143 Kiel, Germany.
Mar Drugs. 2022 Jun 18;20(6):402. doi: 10.3390/md20060402.
Fucoidans, sulfated polysaccharides from brown algae, possess multiple bioactivities in regard to osteogenesis, angiogenesis, and inflammation, all representing key molecular processes for successful bone regeneration. To utilize fucoidans in regenerative medicine, a delivery system is needed which temporarily immobilizes the polysaccharide at the injured site. Hydrogels have become increasingly interesting biomaterials for the support of bone regeneration. Their structural resemblance with the extracellular matrix, their flexible shape, and capacity to deliver bioactive compounds or stem cells into the affected tissue make them promising materials for the support of healing processes. Especially injectable hydrogels stand out due to their minimal invasive application. In the current study, we developed an injectable thermosensitive hydrogel for the delivery of fucoidan based on chitosan, collagen, and β-glycerophosphate (β-GP). Physicochemical parameters such as gelation time, gelation temperature, swelling capacity, pH, and internal microstructure were studied. Further, human bone-derived mesenchymal stem cells (MSC) and human outgrowth endothelial cells (OEC) were cultured on top (2D) or inside the hydrogels (3D) to assess the biocompatibility. We found that the sol-gel transition occurred after approximately 1 min at 37 °C. Fucoidan integration into the hydrogel had no or only a minor impact on the mentioned physicochemical parameters compared to hydrogels which did not contain fucoidan. Release assays showed that 60% and 80% of the fucoidan was released from the hydrogel after two and six days, respectively. The hydrogel was biocompatible with MSC and OEC with a limitation for OEC encapsulation. This study demonstrates the potential of thermosensitive chitosan-collagen hydrogels as a delivery system for fucoidan and MSC for the use in regenerative medicine.
褐藻来源的硫酸多糖岩藻聚糖具有成骨、血管生成和炎症等多种生物活性,这些都是成功骨再生的关键分子过程。为了将岩藻聚糖应用于再生医学,需要一种输送系统,该系统可将多糖暂时固定在受损部位。水凝胶已成为支持骨再生的越来越有吸引力的生物材料。它们与细胞外基质的结构相似性、灵活的形状以及将生物活性化合物或干细胞递送到受影响组织的能力,使它们成为支持愈合过程的有前途的材料。特别是可注射水凝胶因其微创应用而脱颖而出。在本研究中,我们开发了一种基于壳聚糖、胶原和 β-甘油磷酸酯(β-GP)的可注射温敏水凝胶,用于输送岩藻聚糖。研究了物理化学参数,如凝胶时间、凝胶温度、溶胀能力、pH 值和内部微观结构。此外,还在水凝胶上(2D)或内部(3D)培养人源性骨髓间充质干细胞(MSC)和人源性血管生成内皮细胞(OEC),以评估其生物相容性。我们发现,在 37°C 下大约 1 分钟后发生溶胶-凝胶转变。与不含岩藻聚糖的水凝胶相比,岩藻聚糖整合到水凝胶中对上述物理化学参数没有影响或只有轻微影响。释放实验表明,水凝胶在两天和六天后分别释放了 60%和 80%的岩藻聚糖。该水凝胶与 MSC 和 OEC 具有生物相容性,对 OEC 的包封具有局限性。本研究表明,温敏壳聚糖-胶原水凝胶作为岩藻聚糖和 MSC 输送系统在再生医学中的应用潜力。